Table 3.

Cellular changes in HVC and the vVZ

No. of daysLD+T 28SDANOVA
12471428
HVC(n = 6)(n = 7)(n = 8)(n = 7)(n = 7)(n = 5)(n = 6)
    AC-3 cell no.836 ± 142a1351 ± 309a,b1681 ± 222b1062 ± 68a,b865 ± 91a1313 ± 131a,b1081 ± 151a,bF(6, 39)=2.8600, p = 0.0207
(n = 9)(n = 5)(n = 7)(n = 8)(n = 7)(n = 6)(n = 7)
    BrdU-positive neuron no.162 ± 30103 ± 31113 ± 29120 ± 20103 ± 1761 ± 1576 ± 11F(6,42)=2.0819, p = 0.0758
vVZ(n = 5)(n = 5)(n = 6)(n = 9)(n = 5)(n = 6)(n = 6)
    BrdU-positive cell no.631 ± 51a1116 ± 73a,b1680 ± 225a,b2246 ± 303b1018 ± 235a,b893 ± 185a,b1187 ± 149a,bF(6,35)=6.6854, p < 0.0001
Coefficient of determination(n = 6)(n = 5)(n = 6)(n = 8)(n = 5)(n = 5)(n = 4)
    vVZ proliferation to HVC AC-3 no.R2 = 0.8696,
p = 0.0208
R2 = 0.4469,
p = 0.1466
R2 = 0.0028,
p = 0.9212
R2 = 0.4009,
p = 0.5544
R2 = 0.0352,
p = 0.8124
R2 = 0.8641,
p = 0.2404
R2 = 0.9067,
p = 0.0479
  • All values are mean ± SEM.

  • a,bDenotes significant differences across treatment groups.